Dr. Navid Redjal is director of Neurosurgical Oncology at Capital Health. He is a board certified, Harvard trained neurosurgeon with extensive research and clinical background in neuro-oncology. He has been involved in significant translational brain cancer research and neuro-oncology clinical trials with research fellowships at the Dana-Farber Cancer Institute and Massachusetts General Hospital. He specializes in complex brain surgery including awake surgery, language and motor mapping, minimally invasive neuro-endoscopic surgery utilizing detailed MRI-based neuro-navigation with diffuse tensor imaging and intraoperative ultrasound. He also uses the CyberKnife® System to treat a variety of brain and spine tumors.
Partial Data by Infogroup (c) 2024. All rights reserved.
